OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Help
Advanced
Search
22
Results
Show all
Save search
Copy query
Show results for
Unknown
(21)
Transcriptomics
(1)
Organisms
Homo sapiens
(1)
Repository
biostudies-arrayexpress
(1)
Publication Date
2012
(1)
Study type
Transcription profiling by array
(1)
Release Date
2014
(7)
2015
(6)
2012
(3)
2016
(3)
2018
(1)
2013
(1)
2011
(1)
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
Breast cancer survivors' perceptions of survivorship care options.
Not available
S-EPMC4874208
|
biostudies-literature
Cite
Endocrine therapy with or without inhibition of epidermal growth factor receptor and human epidermal growth factor receptor 2: a randomized, double-blind, placebo-controlled phase III trial of fulvestrant with or without lapatinib for postmenopausal women with hormone receptor-positive advanced breast cancer-CALGB 40302 (Alliance).
Not available
S-EPMC4251959
|
biostudies-literature
Cite
Randomized Phase III Trial of Paclitaxel Once Per Week Compared With Nanoparticle Albumin-Bound Nab-Paclitaxel Once Per Week or Ixabepilone With Bevacizumab As First-Line Chemotherapy for Locally Recurrent or Metastatic Breast Cancer: CALGB 40502/NCCTG N063H (Alliance).
Not available
S-EPMC4500830
|
biostudies-literature
Cite
Phase III Trial Evaluating Letrozole As First-Line Endocrine Therapy With or Without Bevacizumab for the Treatment of Postmenopausal Women With Hormone Receptor-Positive Advanced-Stage Breast Cancer: CALGB 40503 (Alliance).
Not available
S-EPMC5012690
|
biostudies-literature
Cite
Genomic analysis reveals that immune function genes are strongly linked to clinical outcome in the North Central Cancer Treatment Group n9831 Adjuvant Trastuzumab Trial.
Not available
S-EPMC4334774
|
biostudies-literature
Cite
Phase I/II study of trastuzumab in combination with everolimus (RAD001) in patients with HER2-overexpressing metastatic breast cancer who progressed on trastuzumab-based therapy.
Not available
S-EPMC3157979
|
biostudies-literature
Cite
Circulating tumor cells and response to chemotherapy in metastatic breast cancer: SWOG S0500.
Not available
S-EPMC4209100
|
biostudies-literature
Cite
Outcomes by tumor subtype and treatment pattern in women with small, node-negative breast cancer: a multi-institutional study.
Not available
S-EPMC4076026
|
biostudies-literature
Cite
Relative Effectiveness of Letrozole Compared With Tamoxifen for Patients With Lobular Carcinoma in the BIG 1-98 Trial.
Not available
S-EPMC4550691
|
biostudies-literature
Cite
TBCRC009: A Multicenter Phase II Clinical Trial of Platinum Monotherapy With Biomarker Assessment in Metastatic Triple-Negative Breast Cancer.
Not available
S-EPMC4451173
|
biostudies-literature
Cite
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets